CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Cytokinetics (CYTK) Reaches A Phase 3 First In Non Obstructive HCM

Phase 3Positive
AI Analysis

Summary

Cytokinetics has initiated a Phase 3 trial for a drug candidate in non-obstructive hypertrophic cardiomyopathy, marking the first Phase 3 study in this indication.

Clinical Trial Data

Phase

Phase 3

Importance:6/10
Sentiment:
0.50
Phase 3HCMcardiologyfirst-in-class
Related Companies

Read the original article

Published by yahoo_finance on September 1, 2026 5:05 AM

Read Original